Cost-Effectiveness of Prophylaxis for Mycobacterium avium Complex Disease
Open Access
- 1 May 1997
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 102 (5) , 50-55
- https://doi.org/10.1016/s0002-9343(97)00201-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Costs to Medicaid of Advancing Immunosuppression in an Urban HIV-Infected Patient Population in MarylandJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Costs of HIV+/AIDS at CD4+ Counts Disease Stages Based on Treatment ProtocolsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Natural History of Opportunistic Disease in an HIV-Infected Urban Clinical CohortAnnals of Internal Medicine, 1996
- The Impact of Prophylaxis on Outcome and Resource Utilization in Pneumocystis carinii PneumoniaChest, 1995
- Incidence Of Clinical Aids Conditions In A Cohort Of Homosexual Men With CD4+ Cell Counts <100/mm3The Journal of Infectious Diseases, 1994
- The Lifetime Cost of Treating a Person With HIVJAMA, 1993
- Incidence and Natural History ofMycobacterium avium-Complex Infections in Patients with Advanced Human Immunodeficiency Virus Disease Treated with ZidovudineAmerican Review of Respiratory Disease, 1992
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992
- Survival of Patients with Acquired Immune Deficiency Syndrome and DisseminatedMycobacterium aviumComplex Infection with and without Antimycobacterial ChemotherapyAmerican Review of Respiratory Disease, 1991
- Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991